Come up with a name for your new list and we'll add to it:
Immunome raised a round of funding on October 15, 2014. Investors include
Robin Hood Ventures.
Immunome is a start-up biopharmaceutical company with a patented native, human antibody platform which enables the company to harness the natural curative power of the human immune system. The Immunom…